Author:
Shirani-Bidabadi Shiva,Tabatabaee Aliye,Tavazohi Nazita,Hariri Amirali,Aref Amir Reza,Zarrabi Ali,Casarcia Nicolette,Bishayee Anupam,Mirian Mina
Subject
Cell Biology,General Medicine,Histology,Pathology and Forensic Medicine
Reference226 articles.
1. Adnan Awad, S., Dufva, O., 2021. RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses. 35, 1087–1099.
2. Mechanisms of acquired tumor drug resistance. Biochimica et biophysica acta;Aleksakhina;Rev. Cancer,2019
3. Three-dimensional cell culture: a breakthrough in vivo;Antoni;Int. J. Mol. Sci.,2015
4. MiRNA182 regulates percentage of myeloid and erythroid cells in chronic myeloid leukemia;Arya;Sci. Rep.,2017
5. Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Kalantari, M., Mohammadinejad, R., Javaheri, T., Sethi, G.J.Ijoms., 2020. Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance. 21, 4002.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献